Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin-Reference-Cited by-同舟云学术

Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin

Published:2015-03 Issue:3 Volume:8 Page:424-433
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

White Harvey D.,Bhatt Deepak L.,Gibson C. Michael,Hamm Christian W.,Mahaffey Kenneth W.,Price Matthew J.,Steg Ph. Gabriel,Stone Gregg W.,Cortese Bernardo,Wilensky Michael,Deliargyris Efthymios N.,Liu Tiepu,Prats Jayne,Harrington Robert A.

Funder

The Medicines Company

Sanofi

Eli Lilly

NIH

Pfizer

Roche

Johnson & Johnson

Schering Plough

Merck Sharpe & Dohme, AstraZeneca

GlaxoSmithKline

Daiichi Sankyo

Pharma Development

Bristol-Myers Squibb

Amarin

AstraZeneca

Eisai

Ethicon

Medtronic

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Effect of platelet inhibition with cangrelor during PCI on ischemic events;Bhatt;N Engl J Med,2013

2. Bivalirudin for patients with acute coronary syndromes;Stone;N Engl J Med,2006

3. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management. One-year results from the ACUITY trial;Stone;JAMA,2007

4. Bivalirudin during primary PCI in acute myocardial infarction;Stone;N Engl J Med,2008

5. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial;Mehran;Lancet,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review;Cureus;2023-09-13

2. High BMI: Another Barrier to Rapid Platelet Inhibition After STEMI PCI;Cardiovascular Drugs and Therapy;2023-08-18

3. Safety of cangrelor and transition to oral P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study;European Heart Journal Open;2023-07

4. Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-02-03

5. Cangrelor in clinical use;Future Cardiology;2020-03